Medschede Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 3.00 M
- Revenue Growth -37.66%
- Profit Growth -6.46%
- Ebitda 40.59%
- Net Worth 10.00%
- Total Assets 31.52%
About Medschede Life Sciences
Medschede Life Sciences Private Limited (MLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 May 2012 and has a history of 12 years and nine months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.00 M.
Syed Jafar, Syed Jafar, and Ashraf Jahan serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33111UP2012PTC050369
-
Company No.
050369
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 May 2012
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Medschede Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Syed Jafar
|
Director | 08-May-2012 | Current |
|
Syed Jafar
|
Director | 08-May-2012 | Current |
|
Ashraf Jahan
|
Director | 12-Sep-2013 | Current |
Financial Performance of Medschede Life Sciences.
Medschede Life Sciences Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 37.66% decrease. The company also saw a slight decrease in profitability, with a 6.46% decrease in profit. The company's net worth by .
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medschede Life Sciences?
In 2018, Medschede Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Feb 2014 | Others | ₹3.00 M | Open |
How Many Employees Work at Medschede Life Sciences?
Unlock and access historical data on people associated with Medschede Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medschede Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medschede Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
